A new high-accuracy low-cost infusion pump has attracted £250,000 funding from The Capital Fund, a £50 million venture capital fund that invests in fast-growth companies in Greater London.
The UK government has moved to promote the wider adoption of non-fossil fuels with a new action plan to unlock the potential for renewable energy in biomass.
Searching for the best tax incentives in European R&D? Then look no further than the Science|Business guide to this popular - though by no means universal - stimulant.
Spend more on basic research - that's one of the prescriptions for Europe offered by Jim Goodnight, founder and CEO of SAS, one of the world's largest privately held software companies.
Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.
Hailed as one of the most important recent discoveries in biology, RNA interference has seen patent applications rise 3,000 per cent between 2000 and 2003.
Philips has announced the first fruit of its deal with the venture capital firm New Venture Partners to spin out companies based on research carried out in Philips’ corporate research laboratories.
A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer
Researchers are taking cues from a century-old spray drying technology to see if it could be developed to make better products for the food and pharmaceutical industries. They are now looking for investors and partnership from industry players.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.